133 related articles for article (PubMed ID: 35924704)
1. [The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer].
Onishi K; Tanaka N; Hori S; Nakai Y; Miyake M; Anai S; Fujimoto K
Hinyokika Kiyo; 2022 Jul; 68(7):217-225. PubMed ID: 35924704
[TBL] [Abstract][Full Text] [Related]
2. Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer.
Owa S; Sasaki T; Ikadai R; Tabata Y; Takeuchi Y; Nishikawa T; Kato M; Higashi S; Sugino Y; Masui S; Nishikawa K; Inoue T
Int J Clin Oncol; 2024 Jun; 29(6):840-846. PubMed ID: 38587577
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.
Iwamoto H; Kano H; Shimada T; Naito R; Makino T; Kadomoto S; Yaegashi H; Shigehara K; Izumi K; Kadono Y; Mizokami A
In Vivo; 2021; 35(3):1703-1709. PubMed ID: 33910855
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
5. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
6. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
[TBL] [Abstract][Full Text] [Related]
7. CT anthropometric analysis of the prognosis of traumatic brain injury: A retrospective study to compare between psoas muscle and abdominal skeletal muscle.
Cho HJ; Hwang Y; Yang SY; Kim M
Injury; 2022 May; 53(5):1652-1657. PubMed ID: 35241285
[TBL] [Abstract][Full Text] [Related]
8. Serum Tumor Necrosis Factor-α Is Inversely Associated With the Psoas Muscle Index in Both Male and Female Patients Scheduled for Living Donor Liver Transplantation.
Shim JW; Yang S; Jung JY; Choi HJ; Chung HS; Hong SH; Park CS; Choi JH; Chae MS
Transplant Proc; 2019; 51(6):1874-1879. PubMed ID: 31262437
[TBL] [Abstract][Full Text] [Related]
9. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in Japan.
Yasuoka S; Yuasa T; Ogawa M; Komai Y; Numao N; Yamamoto S; Kondo Y; Yonese J
Anticancer Res; 2019 Oct; 39(10):5803-5809. PubMed ID: 31570485
[TBL] [Abstract][Full Text] [Related]
11. The psoas muscle index as a predictor of long-term survival after cardiac surgery for hemodialysis-dependent patients.
Kurumisawa S; Kawahito K
J Artif Organs; 2019 Sep; 22(3):214-221. PubMed ID: 31134455
[TBL] [Abstract][Full Text] [Related]
12. Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer.
Fujiwara M; Yuasa T; Yasuoka S; Komai Y; Oguchi T; Fujiwara R; Numao N; Yamamoto S; Yonese J
Cancer Chemother Pharmacol; 2021 Sep; 88(3):525-531. PubMed ID: 34110449
[TBL] [Abstract][Full Text] [Related]
13. Impact of skeletal muscle mass on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Uchida Y; Ishii H; Tanaka A; Yonekawa J; Satake A; Makino Y; Suzuki W; Kurobe M; Mizutani K; Mizutani Y; Fujimoto M; Ichimiya H; Teramoto C; Tamenishi A; Okamoto H; Watanabe J; Kanashiro M; Amano T; Matsubara T; Ichimiya S; Murohara T
Cardiovasc Interv Ther; 2021 Oct; 36(4):514-522. PubMed ID: 33128695
[TBL] [Abstract][Full Text] [Related]
14. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and the Therapeutic Effects of Androgen Receptor-axis-targeted Therapies in Patients With Castration-resistant Prostate Cancer.
Hiroshige T; Ogasawara N; Kumagae H; Ueda K; Chikui K; Uemura KI; Nishihara K; Nakiri M; Matsuo M; Suekane S; Igawa T
In Vivo; 2023; 37(3):1266-1274. PubMed ID: 37103069
[TBL] [Abstract][Full Text] [Related]
16. Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.
Stangl-Kremser J; Suarez-Ibarrola R; Andrea D; Korn SM; Pones M; Kramer G; Marhold M; Krainer M; Enikeev DV; Glybochko PV; Tamandl D; Shariat SF; Baltzer P
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):309-315. PubMed ID: 31745255
[TBL] [Abstract][Full Text] [Related]
17. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
18. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
Deng CY; Lin YC; Wu JS; Cheung YC; Fan CW; Yeh KY; McMahon CJ
AJR Am J Roentgenol; 2018 Mar; 210(3):526-532. PubMed ID: 29364725
[TBL] [Abstract][Full Text] [Related]
19. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
Kosaka T; Hongo H; Oya M
BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer.
Miyoshi Y; Sakamoto S; Kawahara T; Uemura K; Yokomizo Y; Uemura H
Urol Int; 2019; 103(3):279-284. PubMed ID: 31461725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
